FIELD: biochemistry.
SUBSTANCE: invention relates to a method of treating cancer, wherein cancer involves a solid tumor that overexpresses FGFR2IIIb. Also disclosed are use of afucosylated antibody which binds to FGFR2IIIb for treating cancer in an individual, where cancer is a solid tumor, which overexpresses FGFR2IIIb, a kit for treating cancer in an individual, wherein the cancer is a solid tumor that overexpresses FGFR2IIIb.
EFFECT: invention provides effective treatment of cancer associated with overexpression of FGFR2IIIb.
69 cl, 6 ex, 4 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| FGFR2 INHIBITORS SEPARATELY OR IN COMBINATION WITH IMMUNOSTIMULATING AGENTS IN CANCER TREATMENT | 2016 |
|
RU2745707C2 |
| ANTIBODIES TO FGFR2 IN COMBINATION WITH CHEMOTHERAPY IN CANCER TREATMENT | 2018 |
|
RU2797560C2 |
| ANTIBODY-DRUG CONJUGATES AND METHODS OF USING SAID CONJUGATES OF PYRROLOBENZODIAZEPINE | 2016 |
|
RU2736725C1 |
| ANTIBODIES AGAINST CXCR5, THEIR COMPOSITIONS AND USE | 2018 |
|
RU2798422C2 |
| ANTIBODIES TO MYOSTATIN, POLYPEPTIDES CONTAINING FC-REGION VARIANTS, AND THEIR APPLICATION METHODS | 2016 |
|
RU2789884C2 |
| ANTIBODIES TO MYOSTATIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2778945C2 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF THEIR USE | 2019 |
|
RU2800779C2 |
| ANTIBODIES TO LAG3 | 2018 |
|
RU2778053C2 |
| ANTIBODIES TO MYOSTATIN, POLYPEPTIDES CONTAINING FC REGION VARIANTS AND METHODS OF THEIR USE | 2015 |
|
RU2799522C2 |
| ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2771964C2 |
